BackgroundNemtabrutinib is a reversible inhibitor of both wild-type and acquired resistance-related mutant BTK. Since nemtabrutinib biochemically inhibits various kinases, new drug response biomarkers
Estimates of aviation effective radiative forcing (ERF) indicate that contrail cirrus is currently its largest contributor, although with a substantial associated uncertainty of...